Molecular pathological advances and research directions in gliomas
10.3781/j.issn.1000-7431.2024.2401-0043
- VernacularTitle:胶质瘤分子病理进展及方向
- Author:
Ruichao CHAI
1
;
Bo PANG
;
Yilin WU
;
Tao JIANG
Author Information
1. 首都医科大学附属北京市神经外科研究所神经病理中心分子神经病理室,北京 100070
- Publication Type:Journal Article
- Keywords:
Glioma;
Molecular pathology;
Mutation;
Clinic diagnosis and treatment
- From:
Tumor
2024;44(9):891-900
- CountryChina
- Language:Chinese
-
Abstract:
The 5th edition of the World Health Organization(WHO)central nervous system(CNS)tumor classification(WHO CNS 2021),which was published in 2021,introduced a variety of molecular features that highlight the significance of molecular pathology in understanding the pathological mechanisms,diagnostic classification,prognosis assessment,and guidance of treatment for gliomas.This review aimed to summarize the significant advancements in molecular pathology and its practical applications in clinical settings.Moreover,the challenges faced during the development of molecular pathology and its implementation in clinical practice were discussed.Lastly,an outlook on forthcoming developments in this field for the future was provided.
